# Suanfarma Biotech

> Suanfarma Biotech is a VC fund in Alcobendas backing Medical and Biotechnology. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Alcobendas, Spain
- Total investments: 3
- Last investment: Sep 2016
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/649095
- X (Twitter): http://twitter.com/suanfarma
- Website: http://www.suanfarma.com
- Facebook: https://www.facebook.com/pages/Suanfarma-Biotech-SGECR/558009234265371?rf=1413378395551006

Suanfarma Biotech is a VC fund in Alcobendas focused on Medical and Biotechnology. Suanfarma Biotech engages in the development, manufacture, and distribution of raw materials and finished dosage forms for pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. It offers generics and active pharmaceutical ingredients, such as anti-infective, cardiovascular system, central nervous system, digestive system,endocrine system, oncology, respiratory system, and pain and inflammation products; and food supplements, and medicinal and dietary plants, including non-native vegetable species, dietary supplements, plant extracts, jellies, syrups, oligotherapy, litotherapy, etc. Suanfarma Biotech also provides active ingredients for veterinary industry, such as antibiotics, NSAIDs, antiparasitics, glucocorticoids, nutritional, reproduction, and others; and develops alternative routes of synthesis for obtaining active pharmaceutical ingredients and their subsequent industrial scale-up. In addition, it invests in seed and early-stage biotechnology companies; delivers its expertise to biotech companies on issues related to business and commercial management; and provides support on scientific, industrial, regulatory, and financial development. Suanfarma Biotech serves customers in Spain and internationally. It began operation in 1993, with its headquarters in Alcobendas in Spain and locations in Phoenix in Arizona, Fair Lawn in New Jersey, Naucalpan de Juárez in Mexico; Bogotá in Colombia, Caracas in Venezuela, Sao Paulo in Brazil, Buenos Aires in Argentina, Santiago in Chile, Madrid and Barcelona in Spain, Fitbourg in Switzerland, Dubai in the United Arab Emirates, Navi Mumbai in India, and Shanghai in China.

## Contacts

5 contacts available for Suanfarma Biotech. Shizune tracks 3 team members at Suanfarma Biotech. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/suanfarma-biotech?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Biotechnology | 2 | 67% |
| Health Care | 1 | 33% |
| Pharmaceutical | 1 | 33% |
| Health Diagnostics | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Gonzalo Marín Zirotti | Chief Executive Officer | 0 | — |
| Maite Vázquez Calo | Partner | 0 | — |
| Silvia Martín de Cáceres Godoy | Head of Marketing & Communications | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Idifarma Desarrollo Farmacéutico | Idifarma is a leading Spanish CDMO since 2001 that provides services to over 100 international pharmaceutical companies Our main objective is to provide pharmaceutical development and manufacturing services tailored to our clients’ needs. Thanks to our wide range of services, our high-performance equipment and a strict quality control system, wecan offer efficient solutions within set deadlines. |  |  | Sep 18, 2016 |  |
| Idifarma Desarrollo Farmacéutico | Idifarma is a leading Spanish CDMO since 2001 that provides services to over 100 international pharmaceutical companies Our main objective is to provide pharmaceutical development and manufacturing services tailored to our clients’ needs. Thanks to our wide range of services, our high-performance equipment and a strict quality control system, wecan offer efficient solutions within set deadlines. |  |  | Sep 18, 2016 |  |
| Digna Biotech | Digna Biotech is a spin-off of the Centre for Applied Medical Research (CIMA) of the University of Navarra in Pamplona, jointly owned by the Foundation for Applied Medical Research (Fundacian para la Investigacian Macdica Aplicada, FIMA), and a consortium of private investors. Among the latter are some of the mayor corporations of Spain, incluidingmajor institutions of Navarra such as University of Navarra, Caja Navarra, Caja Rural de Navarra, and the Government of Navarra through its investment arm SODENA. |  |  | Oct 23, 2007 |  |

3 of 3 investments shown.

## Co-investors
- [Clave Mayor](https://shizune.co/investors/profile/clave-mayor) — VC Fund, 3 deals together
- [SODENA](https://shizune.co/investors/profile/sodena) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Suanfarma Biotech invest in?

Suanfarma Biotech invests primarily in Medical, Biotechnology and Health Care startups, most often at Funding Round stage. Most of the 3 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Suanfarma Biotech?

Public channels for Suanfarma Biotech include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Suanfarma Biotech?

The team at Suanfarma Biotech includes Gonzalo Marín Zirotti (Chief Executive Officer), Maite Vázquez Calo (Partner) and Silvia Martín de Cáceres Godoy (Head of Marketing & Communications). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co